SMTL ID : 7zej.1

Crystal structure of the human MGC45594 gene product in complex with celecoxib.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.79 Å

Oligo State

homo-dimer

Ligands

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 34 residues within 4Å: Chain A: N.45, A.46, S.47, V.125, S.126, T.129, A.150, G.153, G.154, T.155, T.173, C.174, S.175, K.179, Y.194, S.217, V.218, I.239, G.240, F.241, I.242, S.243, Y.245, Q.246, F.273, F.274, L.275, M.326, Y.327, G.329, N.331, G.333 Chain B: L.264 Ligands: CEL.2 26 PLIP interactions: 26 interactions with chain A Hydrophobic interactions: A:V.125, A:T.129 Hydrogen bonds: A:A.46, A:S.47, A:G.154, A:T.155, A:S.175, A:K.179, A:S.217, A:I.239, A:F.241, A:I.242, A:Y.245, A:L.275, A:G.329, A:N.331 Water bridges: A:S.47, A:S.126, A:S.126, A:A.150, A:G.153, A:G.156, A:T.173, A:Y.194, A:Y.327 Salt bridges: A:K.179 NAP.3: 34 residues within 4Å: Chain A: L.264 Chain B: N.45, A.46, S.47, V.125, S.126, T.129, A.150, G.153, G.154, T.155, T.173, C.174, S.175, K.179, Y.194, S.217, V.218, I.239, G.240, F.241, I.242, S.243, Y.245, Q.246, F.273, F.274, L.275, M.326, Y.327, G.329, N.331, G.333 Ligands: CEL.4 23 PLIP interactions: 23 interactions with chain B Hydrophobic interactions: B:V.125, B:T.129 Hydrogen bonds: B:A.46, B:T.129, B:G.154, B:T.155, B:S.175, B:K.179, B:I.239, B:I.242, B:Y.245, B:L.275, B:G.329, B:N.331 Water bridges: B:S.47, B:S.126, B:S.126, B:A.150, B:G.153, B:G.156, B:T.173, B:Y.194 Salt bridges: B:K.179

2 x CEL: 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE(Non-covalent)

CEL.2: 15 residues within 4Å: Chain A: S.47, N.50, R.55, Y.56, I.239, F.241, Y.245, T.249, G.250, L.251, F.274 Chain B: A.261, L.264, K.265 Ligands: NAP.1 11 PLIP interactions: 7 interactions with chain A, 4 interactions with chain B Hydrophobic interactions: A:Y.56, A:Y.56, A:F.241, A:Y.245, A:L.251, A:F.274, B:L.264, B:K.265 Hydrogen bonds: A:S.47, B:K.265 pi-Cation interactions: B:K.265 CEL.4: 16 residues within 4Å: Chain A: A.261, L.264, K.265 Chain B: S.47, N.50, R.55, Y.56, I.239, G.240, F.241, Y.245, T.249, G.250, L.251, F.274 Ligands: NAP.3 10 PLIP interactions: 8 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:N.50, B:L.251, B:F.274, B:F.274, A:L.264, A:K.265 Hydrogen bonds: B:S.47 pi-Stacking: B:Y.56, B:F.241 Halogen bonds: B:I.239

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shafqat, N. et al., Human prostaglandin/alkenal reductases: substrate specificities, inhibitor profiles, structural insights and subcellular localization suggest protective roles in inflammatory and oxidative stress conditions. To Be Published

Release Date

2022-05-04

Peptides

Prostaglandin reductase 3: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Prostaglandin reductase 3

Related Entries With Identical Sequence